The views and opinions expressed in this report represent those of the joint Wellcome Trust / The Boston Consulting Group project team, and do not necessarily reflect those of the individuals and organisations named below.

Experts Consulted

This publication synthesises many insights from interviews with experts. The project team wishes to thank them for their time, dedication and guidance.

  • Jon Abramson; Former Chair, World Health Organisation SAGE Committee
  • Frank Baehner; Area Head, Prophylactic Vaccines CureVac AG
  • Rip Ballou; Vice President and Head, Global Vaccines US R&D Center, GlaxoSmithKline
  • Steven Black; Professor, UC Department of Pediatrics and Attending Paediatrician Cincinnati Children’s Hospital
  • Marco Cavaleri; Head of Office, Anti-infectives and Vaccines in the Human Medicines Evaluation Division, European Medicines Agency
  • David Cho; Lead Scientific Reviewer, Center for Devices and Radiological Health, Food and Drug Administration, United States
  • Ralf Clemens; Former Senior Vice President, Vaccine Development, Takeda
  • ​Martin Friede; Coordinator, Initiative for Vaccine Research, World Health Organisation
  • Bruce Gellin; President, Global Immunisation, Sabin Vaccine Institute; Former Director, United States National Vaccine Program Office
  • Birgitte Giersing; Technical Officer, Initiative for Vaccine Research, World Health Organisation
  • Herman Goossens; Professor and Director, Department of Clinical Pathology, University Hospital, Antwerp
  • Arjon von Hangel; Health Directorate of the Directorate-General for Research and Innovation, European Commission
  • ​Adrian Hill; Professor and Director, Jenner Institute, University of Oxford
  • Suresh Jadhav; Executive Director, Serum Institute of India
  • Kathrin Jansen; Senior Vice President and Head, Vaccine Research & Development, Pfizer
  • Chris Karp; Director, Discovery & Translational Sciences, Bill and Melinda Gates Foundation
  • Nicholas Kartsonis; Vice President and Therapeutic Area Head, Clinical Research – Infectious Disease, Merck
  • Barbara Kerstiens; Technical Officer, Initiative for Vaccine Research, World Health Organisation
  • Jerome Kim; Director General, International Vaccine Institute
  • Joseph Kim; Chief Executive Officer, Innovio Pharmaceuticals
  • Wayne Koff; Chief Executive Officer, Human Vaccines Project
  • F ​Marc LaForce; Director, Technical Services, Serum Institute of India
  • ​Jean Lang; Associate Vice President, Sanofi Pasteur
  • Calman MacLennan; Senior Programme Officer for Bacterial Vaccines in Global Health, Bill and Melinda Gates Foundation; Senior Clinical Fellow, University of Oxford; and Consultant Immunologist, Oxford University Hospitals
  • Christian Mandl; Former Senior Vice President, RNA technologies, Vir
  • Michael McConnell; Investigator in the Institute for Biomedical Research in Seville; Chief Scientific Officer, Vaxdyn
  • Helen McShane; Professor, Vaccinology and Honorary Consultant in HIV and Genito-Urinary Medicine, University of Oxford
  • ​Aurelia Nguyen; Managing Director, Vaccines and Sustainability, Gavi Secretariat
  • Kevin Outterson; Executive Director, CARB-X, Neal Pike Scholar in Health and Disability Law and Professor, Boston University
  • Jonathan Pearce; Head, Infection and Immunity, Medical Research Council
  • James Platts-Mills; Assistant Professor, Infectious Diseases and International Health, University of Virginia School of Medicine
  • Andrew Pollard; Professor, Paediatric Infection and Immunity, University of Oxford; Honorary Consultant Paediatrician, Children’s Hospital, Oxford
  • ​Jan Poolman; Head Bacterial Vaccine Discovery and Early Development, Janssen
  • Rino Rappouli; Chief Scientist and Head External R&D, GlaxoSmithKline Vaccines
  • David Salisbury; Associate Fellow, Centre on Global Health Security, Chatham House; former Chair, World Health Organisation SAGE Committee
  • Allan Saul; Director, GSK Vaccines Institute for Global Health
  • George Siber; Former Executive Vice President and Chief Scientific Officer, Wyeth Vaccines; Adjunct Professor, Johns Hopkins Bloomberg School of Public Health
  • Duncan Steele; Deputy Director, Enteric and Diarrhoeal Diseases, Bill and Melinda Gates Foundation
  • Phil Sutton; Associate Professor, Murdoch Children’s Research Institute
  • Magnus Unemo; Associate Professor, Medical Microbiology and Molecular Biology, Örebro University, Sweden
  • Johan Vekemans; Medical Officer, Initiative for Vaccine Research, World Health Organisation
  • Malabi Venkatesan; Investigator, Department of Bacterial Immunology, Walter Reed Army Institute of Research
  • Richard Walker; Director, Enteric Vaccine Initiative, PATH
  • ​James Wassil; Vice President and Global Health and Vaccines Business Unit Head, Pfizer
  • David Wyllie; Senior Clinical Research Fellow, University of Oxford; Honorary Consultant, Microbiology, Oxford University Hospitals

Project Team

The Boston Consulting Group (BCG)

  • John Gooch; Senior Partner and Managing Director, London
  • Andrew Rodriguez; Partner and Managing Director, Munich
  • Emily Serazin; Partner and Managing Director, Washington DC
  • Monica Schwarm; Project Leader, London
  • Asher Steene; Consultant, London
  • Benedict Halbroth; Junior Consultant, Berlin
  • Sanjay Budhdeo; Senior Associate, London
  • Emma Clifton; Intern, London
  • Yane Yane Cheng; Senior Knowledge Analyst, Paris